These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 24298923)

  • 1. Content analysis of continuing education for cervical cytology.
    Holter VL; Crenshaw JT; Gilder RE
    Int J Evid Based Healthc; 2013 Dec; 11(4):291-8. PubMed ID: 24298923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Content analysis of continuing medical education for cervical cancer screening.
    Roland KB; Larkins TL; Benard VB; Berkowitz Z; Saraiya M
    J Womens Health (Larchmt); 2010 Apr; 19(4):651-7. PubMed ID: 20350199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
    Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
    Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
    Perkins RB; Anderson BL; Gorin SS; Schulkin JA
    Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
    Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
    Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
    J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of patient comfort and adherence with less frequent cervical cancer screening.
    MacLaughlin KL; Angstman KB; Flynn PM; Schmitt JR; Weaver AL; Shuster LT
    Qual Prim Care; 2011; 19(6):355-63. PubMed ID: 22340898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
    Papa D; Moore Simas TA; Reynolds M; Melnitsky H
    J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human papillomavirus in women over 40: implications for practice and recommendations for screening.
    Montgomery K; Bloch JR
    J Am Acad Nurse Pract; 2010 Feb; 22(2):92-100. PubMed ID: 20132367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
    Wright TC
    Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
    McCaffery K; Irwig L
    J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary human papillomavirus testing in organized cervical screening.
    Dillner J
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):11-6. PubMed ID: 23299089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current guidelines for cervical cancer screening.
    Schwaiger C; Aruda M; LaCoursiere S; Rubin R
    J Am Acad Nurse Pract; 2012 Jul; 24(7):417-24. PubMed ID: 22735065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
    Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
    J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines.
    Almonte M; Sasieni P; Cuzick J
    Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):617-29. PubMed ID: 21683657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Jun; 156(12):880-91, W312. PubMed ID: 22711081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of primary HPV screening for cervical cancer in Germany--a decision analysis.
    Sroczynski G; Schnell-Inderst P; Mühlberger N; Lang K; Aidelsburger P; Wasem J; Mittendorf T; Engel J; Hillemanns P; Petry KU; Krämer A; Siebert U
    Eur J Cancer; 2011 Jul; 47(11):1633-46. PubMed ID: 21482103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do cervical cancer screening patient information leaflets meet the HPV information needs of women?
    Hall B; Howard K; McCaffery K
    Patient Educ Couns; 2008 Jul; 72(1):78-87. PubMed ID: 18372144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening in adolescents: an evidence-based internet education program for practice improvement among advanced practice nurses.
    Choma K; McKeever AE
    Worldviews Evid Based Nurs; 2015 Feb; 12(1):51-60. PubMed ID: 25495998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer screening among women who attend sexually transmitted diseases (STD) clinics: background paper for 2010 STD Treatment Guidelines.
    Datta SD; Saraiya M
    Clin Infect Dis; 2011 Dec; 53 Suppl 3():S153-9. PubMed ID: 22080268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.